Randomized clinical trial of homocysteine level-lowering therapy and fractures

Archives of Internal Medicine

Volumn 167, Issue 19, 2007, Pages 2136-2139

  Sawka, Anna M ^a   Ray, Joel G ^b   Yi, Qilong ^b   Josse, Robert G ^b   Lonn, Eva ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PLACEBO; PYRIDOXINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG MECHANISM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; UNSPECIFIED SIDE EFFECT; VERTEBRA FRACTURE;

AGED; CARDIOVASCULAR DISEASES; DRUG THERAPY, COMBINATION; FEMALE; FOLIC ACID; FRACTURES, BONE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PYRIDOXINE; RISK FACTORS; TREATMENT OUTCOME; VITAMIN B 12;

EID: 35648974867     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.19.2136     Document Type: Article

References (21)

1. van Meurs JB, Dhonukshe-Ruten RA, Pluijm SMF, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med. 2004;350(20):2033- 2041.
2. 12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in health elderly people. J Bone Miner Res. 2005;20(6):921-929.
3. McLean RR, Jacques PF, Selhub J, et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med. 2004;350(20):2042-2049.
4. Jamal SA, Leiter RE, Bauer DC. Hyperhomocysteinaeimia and aortic calcification are associated with fractures in patients on haemodialysis. QJM. 2005;98(8):575-579.
5. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Homocysteine as a predictive factor for hip fracture in stroke patients. Bone. 2005;36(4):721-726.
6. 12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial. Can J Cardiol. 2006;22(1):47-53.
7. Lonn E, Yusuf S, Arnold MJ, et al; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease.N Engl J Med. 2006;354(15):1567-1577.
8. 12 and the risk of hip fracture: the Hordaland Homocysteine Study [published online ahead of print February 12, 2007]. J Bone Miner Res. doi:10.1359/JBMR.070210.
9. American Society of Human Genetics/American College of Medical Genetics Test and Technology Transfer Committee Working Group. Measurement and use of total plasma homocysteine. Am J Hum Genet. 1998;63(5):1541-1543.
10. Ravaglia G, Forti P, Maioli F, et al. Folate, but not homocysteine, predicts the risk of fracture in elderly persons. J Gerontol A Biol Sci Med Sci. 2005;60(11):1458-1462.
11. Koh JM, Lee YS, Kim KS, et al. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res. 2006;21(7):1003-1011.
12. Gerdhem P, Ivaska KK, Isaksson A, et al. Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res [Am]. 2007;22(1):127-134.
13. Green TJ, McMahon JA, Skeaff CM, Williams SM, Whiting SJ. Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial. Am J Clin Nutr. 2007;85(2):460-464.
14. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke. JAMA. 2005;293(9):1082-1088.
15. Cumming RG. Nursing home residence and risk of hip fracture. Am J Epidemiol. 1996;143(12):1191-1194.
16. Brennan nee Saunders J, Johansen A, Butler J, et al. Place of residence and risk of fracture in older people: a population-based study of over 65-year-olds in Cardiff. Osteoporos Int. 2003;14(6):515-519.
17. Ooms ME, Vlasman P, Lips P, Nauta J, Bouter LM, Valkenburg HA. The incidence of hip fractures in independent and institutionalized elderly people. Osteoporos Int. 1994;4(1):6-10.
18. Norton R, Campbell AJ, Reid IR, et al. Residential status and risk of hip fracture. Age Ageing. 1999;28(2):135-139.
19. Butler M, Norton R, Lee-Joe T, Cheng A, Campbell AJ. The risks of hip fracture in older people from private homes and institutions. Age Ageing. 1996;25(5):381-385.
20. Bønaa KH, Njolstad I, Ueland PM, et al; NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354(15):1578-1588.
21. Lenth RV. Java Applets for power and sample size (SAS software). http://www.stat.uiowa.edu/~rlenth/Power. Accessed April 13, 2007.